Clover Health is a health insurance company driving to improve the overall state of healthcare in America by integrating the company's systems with doctors, clinicians, and nurse practitioners to help healthcare professionals in the field intervene directly into patients’ wellness to help them avoid acute health episodes.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/10/2017 | Series D | $130MM | $xx.xx | $123.39B | Baillie Gifford, Expanding Capital, First Round Capital, Greenoaks Capital, Gv, Palm Drive Capital, Sequoia Capital, Toba Capital, Western Technology Investment | |
Price per Share
$xx.xx
Shares Outstanding
13,862,526
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Baillie Gifford, Expanding Capital, First Round Capital, Greenoaks Capital, Gv, Palm Drive Capital, Sequoia Capital, Toba Capital, Western Technology Investment
|
||||||
05/23/2016 | Series C | $160.17MM | $xx.xx | $83.5B | Ame Cloud Ventures, Arena Ventures, Casdin Capital, First Round Capital, Floodgate Fund, Greenoaks Capital, Nexus Venture Partners, Refactor Capital, Sequoia Capital, Social Capital, Spark Capital, Wildcat Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
19,066,809
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ame Cloud Ventures, Arena Ventures, Casdin Capital, First Round Capital, Floodgate Fund, Greenoaks Capital, Nexus Venture Partners, Refactor Capital, Sequoia Capital, Social Capital, Spark Capital, Wildcat Venture Partners
|
||||||
01/05/2016 | Series A-1 | $7.5MM | $xx.xx | $7.8B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
7,199,261
Liquidation Pref Order
2
Liquidation Pref As Multiplier
3.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
01/05/2016 | Series A | $5.5MM | $xx.xx | $7.05B | Athyrium Capital Mgmt, First Round Capital, Nathaniel Turner, Oxeon Partners | |
Price per Share
$xx.xx
Shares Outstanding
5,274,468
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Athyrium Capital Mgmt, First Round Capital, Nathaniel Turner, Oxeon Partners
|
||||||
12/16/2015 | Series B | $35MM | $xx.xx | $26.3B | Athyrium Capital Mgmt, First Round Capital, Sequoia Capital, Social Capital, Wildcat Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
10,338,818
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Athyrium Capital Mgmt, First Round Capital, Sequoia Capital, Social Capital, Wildcat Venture Partners
|